Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

MetroBiotech is a biotechnology company pioneering next-generation NAD+ boosting therapies to target age-related diseases and improve human healthspan. Leveraging cutting-edge research in metabolism and longevity, we develop innovative small molecule therapies designed to restore cellular energy and function. Our lead programs focus on conditions linked to mitochondrial dysfunction, including neurodegenerative, cardiovascular,...
MetroBiotech is a biotechnology company pioneering next-generation NAD+ boosting therapies to target age-related diseases and improve human healthspan. Leveraging cutting-edge research in metabolism and longevity, we develop innovative small molecule therapies designed to restore cellular energy and function. Our lead programs focus on conditions linked to mitochondrial dysfunction, including neurodegenerative, cardiovascular, and inflammatory diseases. With a strong foundation in scientific discovery and translational medicine, MetroBiotech is committed to advancing novel therapeutics that redefine healthy aging.

List your booth number for exhibitions, ask us